1,630
Views
19
CrossRef citations to date
0
Altmetric
Research Paper

Pain control methods in use and perceived effectiveness by patients with Ehlers–Danlos syndrome: a descriptive study

, , &
Pages 1063-1074 | Received 23 Jul 2014, Accepted 06 Sep 2015, Published online: 24 Oct 2015

References

  • Berglund B, Anne-Cathrine M, Randers I. Dignity not fully upheld when seeking health care: experiences expressed by individuals suffering from Ehlers–Danlos syndrome. Disabil Rehabil 2010;32:1–7.
  • Rombaut L, Malfait F, Cools A, et al. Musculoskeletal complaints, physical activity and health-related quality of life among patients with the Ehlers–Danlos syndrome hypermobility type. Disabil Rehabil 2010;32:1339–45.
  • Voermans NC, Knoop H, Bleijenberg G, van Engelen BG. Pain in Ehlers–Danlos syndrome is common, severe, and associated with functional impairment. J Pain Symptom Manage 2010;40:370–8.
  • Tinkle B. Issues and management of joint hypermobility: a guide for the Ehlers–Danlos Syndrome hypermobility type and the hypermobility syndrome. Greens Fork (IN): Left Paw Press; 2008.
  • Kemp CA, Ersek M, Turner JA. A descriptive study of older adults with persistent pain: use and perceived effectiveness of pain management strategies. BMC Geriatr 2005;5:12
  • Warms CA, Turner JA, Marshall HM, Cardenas DD. Treatments for chronic pain associated with spinal cord injuries: many are tried, few are helpful. Clin J Pain 2002;18:154–63.
  • Ehlers–Danlos National Foundation. Pain management medical resource guide. 2007. Available from: http://ednf.org/sites/default/files/MRGPainManagementS.pdf [last accessed 15 July 2015].
  • Amtmann D, Cook KF, Jensen MP, et al. Development of a PROMIS item bank to measure pain interference. Pain 2010;150:173–82.
  • Patient Reported Outcome Measurement System. Pain interference scoring manual. 2014. Available from: https://www.assessmentcenter.net/documents/PROMIS%20Pain%20Interference%20Scoring%20Manual.pdf [last accessed 1 May 2014].
  • Cella D, Lai J, Nowinski CJ, et al. Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology 2012;78:1860–7.
  • Salsman J, Victorson D, Choi S, et al. Development and validation of the positive affect and well-being scale for the neurology quality of life (Neuro-QoL) measurement system. Qual Life Res 2013;22:2569–80.
  • National Institute of Neurological Disorders and Stroke (NINDS). User manual for the quality of life in neurological disorders (Neuro-QOL) measures. 2010. http://www.neuroqol.org/Resources/Resources%20documents/Neuro-QOL-UserManual-2013.pdf. [last accessed 14 Apr 2014].
  • Revicki DA, Chen W, Harnam M, et al. Development and psychometric analysis of the PROMIS Pain Behavior item bank. Pain 2009;146:158–69.
  • Patient Reported Outcome Measurement System. Pain behavior: a brief guide to the PROMIS pain behavior instruments. 2014. Available from: https://www.assessmentcenter.net/documents/PROMIS%20Pain%20Behavior%20Scoring%20Manual.pdf [last accessed 1 May 2014].
  • Jenkins S, Sauls L. So you think you might have EDS? Ehlers–Danlos National Foundation; 2009. Available from: http://www.ednf.org/images/stories/leaflets/soyouthinkyoumighthaveeds.pdf [last accessed 15 July 2015].
  • Oregon Area Ehlers–Danlos Support Group. About Ehlers–Danlos syndrome. Available from: http://www.oreds.org/about-eds.html [last accessed 30 Jul 2015].
  • Terry RH, Palmer ST, Rimes KA, et al. Living with joint hypermobility syndrome: patient experiences of diagnosis, referral and self-care. Fam Pract 2015;32:354–8.
  • Gazit Y, Nahir M, Grahame R, Jacob G. Dysautonomia in the joint hypermobility syndrome. Am J Med 2003;115:33–40.
  • Morgan AW, Pearson SB, Davies S, et al. Asthma and airways collapse in two heritable disorders of connective tissue. Ann Rheum Dis 2007;66:1369–73.
  • Rombaut L, Malfait F, De Paepe A, et al. Impairment and impact of pain in female patients with Ehlers–Danlos syndrome: a comparative study with fibromyalgia and rheumatoid arthritis. Arthritis Rheum 2011;63:1979–87.
  • Berglund B, Pettersson C, Pigg M, Kristiansson P. Self-reported quality of life, anxiety and depression in individuals with Ehlers–Danlos syndrome (EDS): a questionnaire study. BMC Musculoskelet Disord 2015;16:89–93.
  • El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014;63:871–80.
  • Ghibellini G, Brancati F, Castori M. Neurodevelopmental attributes of joint hypermobility syndrome/Ehlers–Danlos syndrome, hypermobility type: update and perspectives. Am J Med Genet C Semin Med Genet 2015;169C:107–16.
  • Castori M, Morlino S, Pascolini G, et al. Gastrointestinal and nutritional issues in joint hypermobility syndrome/Ehlers–Danlos syndrome, hypermobility type. Am J Med Genet C Semin Med Genet 2015;169C:54–75.
  • Grigoriou E, Boris JR, Dormans JP. Postural orthostatic tachycardia syndrome (POTS): association with Ehlers–Danlos syndrome and orthopaedic considerations. Clin Orthop Relat Res 2015;473:722–8.
  • Baeza-Velasco C, Pailhez G, Bulbena A, Baghdadli A. Joint hypermobility and the heritable disorders of connective tissue: clinical and empirical evidence of links with psychiatry. Gen Hosp Psychiatry 2015;37:24–30.
  • National Center for Environmental Health. Asthma surveillance data. Atlanta, GA; Centers for Disease Control and Prevention (US); 2015, Available from: http://www.cdc.gov/asthma/asthmadata.htm [last accessed 30 July 2015].
  • National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. Fibromyalgia. Atlanta, GA: Centers for Disease Control and Prevention (US); 2015. Available from: http://www.cdc.gov/arthritis/basics/fibromyalgia.htm [last accessed 30 Jul 2015].
  • National Fibromyalgia and Chronic Pain Association. American College of Rheumatology (ACR) meeting report: Ehlers–Danlos Syndrome and fibromyalgia. Logan (UT); 2014. Available from: http://www.fmcpaware.org/acr-meeting-report-ehlers-danlos-syndrome-and-fm.html [last accessed 30 Jul 2015].
  • Food and Drug Administration (US) [FDA]. Medication guide: Neurontin. Washington (DC); 2013. 6 pp. Available from: http://www.fda.gov/downloads/drugs/drugsafety/ucm229208.pdf [last accessed 1 Aug 2015].
  • Smith TO, Bacon H, Jerman E, et al. Physiotherapy and occupational therapy interventions for people with benign joint hypermobility syndrome: a systematic review of clinical trials. Disabil Rehabil 2014;36: 797–803.
  • Paans N, van den Akker-Scheek I, Dilling RG, et al. Effect of exercise and weight loss in people who have hip osteoarthritis and are overweight or obese: a prospective cohort study. Phys Ther 2013;93:137–46.
  • Ahlström G. Experiences of loss and chronic sorrow in persons with severe chronic illness. J Clin Nurs 2007;16:76–83.
  • Rombaut L, Malfait F, De Wandele I, et al. Medication, surgery, and physiotherapy among patients with the hypermobility type of Ehlers–Danlos Syndrome. Arch Phys Med Rehabil 2011;92:1106–12.
  • Olson T. Physical therapy management of the hypermobile patient. EDNF Conference; 2005; Los Angeles. Available from: http://www.ednf.org/medical-professionals/physical-therapy-management-hypermobile-patient [last accessed 29 Jul 2015].
  • Rombaut L, Deane J, Simmonds J, et al. Knowledge, assessment, and management of adults with joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type among Flemish physiotherapists. Am J Med Genet C Semin Med Genet 2015;169C:76–83.
  • Ehlers–Danlos National Foundation. Vascular Type. McLean (VA): EDNF Ehlers–Danlos National Foundation; 2015. Available from: http://www.ednf.org/vascular-type [last accessed 30 Jul 2015].
  • Shirley E, DeMaio M, Bodurtha J. Ehlers–Danlos Syndrome in orthopaedics: etiology, diagnosis, and treatment implications. Sports Health 2012;4:394–403.
  • Berglund B, Nordström G, Hagberg C, Mattiasson A. Foot pain and disability in individuals with Ehlers–Danlos syndrome (EDS): impact on daily life activities. Disabil Rehabil 2005;27:164–9.
  • Glucklich A. Sacred pain: hurting the body for the sake of soul. New York: Oxford University Press; 2001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.